Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDeane, A.-
dc.contributor.authorYoung, R.-
dc.contributor.authorChapman, M.-
dc.contributor.authorFraser, R.-
dc.identifier.citationCritical Care and Resuscitation, 2008; 10(1):71-71-
dc.description.abstractThe first four authors advise caution in the use of tegaserod as a prokinetic agent for rescue therapy in patients intolerant of nasogastric feeding. The authors of the original audit provide a response.-
dc.publisherAustralasian Academy of Critical Care Medicine-
dc.subjectGastrointestinal Agents-
dc.subjectIntensive Care Units-
dc.subjectClinical Audit-
dc.titleA clinical audit of the efficacy of tegaserod as a pokinetic agent in the intensive care unit-
dc.typeJournal article-
dc.identifier.orcidDeane, A. [0000-0002-7620-5577]-
dc.identifier.orcidChapman, M. [0000-0003-0710-3283]-
Appears in Collections:Aurora harvest
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.